Drug delivery research and development

Skyepharma’s research and development specialises in oral and inhalation drug delivery technologies. Around 80 employees from a variety of countries work together in our facilities in Muttenz, near Basel in Switzerland. The majority of these are scientists, many of whom hold advanced qualifications, and have many years of experience of undertaking innovative research and development.

Skyepharma’s scientists have extensive oral and inhalation drug delivery expertise and apply powder and particle engineering and process technologies to the development of robust formulations.

Our track record with inhalation products includes successful development of both dry powder inhalers (DPIs) and metered dose inhalers (MDIs) with products achieving approvals in over 30 countries worldwide. Our latest inhalation product, flutiform®, has further confirmed our capabilities in complex inhalation product development from original concept to commercial scale manufacture and supply.

Our considerable experience with oral solid dose manufacturing, especially press-coating and multi-layer tableting means that any formulation that we develop is readily transferrable to pilot and commercial scale production. Oral products using Skyepharma technologies have achieved in-market sales of approximately US$4bn over the last 5 years.

> Find out more about our inhalation product development 
> Find out more about oral drug delivery

> Download a leaflet [PDF 800 KB]

Skyepharma's research and development laboratories in Switzerland

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.